Concepts (130)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vaccines | 3 | 2023 | 367 | 1.680 |
Why?
|
| Software | 3 | 2024 | 669 | 1.070 |
Why?
|
| Computational Biology | 5 | 2024 | 790 | 0.880 |
Why?
|
| Artificial Intelligence | 2 | 2024 | 231 | 0.850 |
Why?
|
| DNA | 2 | 2024 | 1606 | 0.680 |
Why?
|
| Viral Vaccines | 1 | 2022 | 324 | 0.650 |
Why?
|
| Algorithms | 1 | 2024 | 1569 | 0.560 |
Why?
|
| Protein Interaction Maps | 1 | 2016 | 77 | 0.510 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2016 | 179 | 0.490 |
Why?
|
| Proteome | 1 | 2016 | 231 | 0.460 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 352 | 0.430 |
Why?
|
| Plasmodium falciparum | 2 | 2024 | 64 | 0.410 |
Why?
|
| Epitopes, B-Lymphocyte | 2 | 2022 | 32 | 0.390 |
Why?
|
| Retroelements | 1 | 2011 | 41 | 0.380 |
Why?
|
| Internet | 2 | 2024 | 367 | 0.350 |
Why?
|
| Obesity | 1 | 2016 | 1938 | 0.250 |
Why?
|
| Merozoites | 1 | 2024 | 2 | 0.240 |
Why?
|
| Proteins | 2 | 2023 | 1039 | 0.230 |
Why?
|
| Entamoeba histolytica | 3 | 2011 | 18 | 0.230 |
Why?
|
| Long Interspersed Nucleotide Elements | 3 | 2011 | 35 | 0.230 |
Why?
|
| Thermodynamics | 1 | 2024 | 141 | 0.220 |
Why?
|
| Sequence Analysis, DNA | 3 | 2024 | 1759 | 0.220 |
Why?
|
| Protozoan Proteins | 1 | 2024 | 109 | 0.220 |
Why?
|
| Antigens | 1 | 2023 | 156 | 0.210 |
Why?
|
| Vaccines, Subunit | 1 | 2022 | 66 | 0.200 |
Why?
|
| Vibrio cholerae | 1 | 2021 | 26 | 0.190 |
Why?
|
| Cholera | 1 | 2021 | 25 | 0.190 |
Why?
|
| Molecular Docking Simulation | 1 | 2022 | 113 | 0.190 |
Why?
|
| Base Sequence | 3 | 2024 | 3117 | 0.190 |
Why?
|
| Malaria, Falciparum | 1 | 2021 | 46 | 0.190 |
Why?
|
| Bacterial Vaccines | 1 | 2021 | 101 | 0.190 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2021 | 125 | 0.180 |
Why?
|
| Phytotherapy | 1 | 2021 | 49 | 0.180 |
Why?
|
| Protozoan Vaccines | 1 | 2021 | 96 | 0.180 |
Why?
|
| Trypanosoma cruzi | 1 | 2021 | 228 | 0.150 |
Why?
|
| Chagas Disease | 1 | 2021 | 286 | 0.150 |
Why?
|
| Escherichia coli | 1 | 2022 | 983 | 0.140 |
Why?
|
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2016 | 16 | 0.130 |
Why?
|
| Short Interspersed Nucleotide Elements | 2 | 2006 | 19 | 0.130 |
Why?
|
| Lactones | 1 | 2016 | 32 | 0.130 |
Why?
|
| Anti-Obesity Agents | 1 | 2016 | 22 | 0.130 |
Why?
|
| Body Fat Distribution | 1 | 2016 | 27 | 0.130 |
Why?
|
| Animals | 6 | 2023 | 33878 | 0.130 |
Why?
|
| Data Mining | 1 | 2016 | 53 | 0.130 |
Why?
|
| Leptin | 1 | 2016 | 205 | 0.120 |
Why?
|
| Humans | 12 | 2024 | 121798 | 0.110 |
Why?
|
| Protein Binding | 1 | 2016 | 1736 | 0.100 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 1007 | 0.090 |
Why?
|
| Insulin | 1 | 2016 | 1189 | 0.090 |
Why?
|
| Heart | 1 | 2015 | 725 | 0.090 |
Why?
|
| Myocardium | 1 | 2015 | 983 | 0.090 |
Why?
|
| MicroRNAs | 1 | 2015 | 836 | 0.080 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 2539 | 0.070 |
Why?
|
| India | 4 | 2021 | 218 | 0.070 |
Why?
|
| Genome, Protozoan | 1 | 2005 | 26 | 0.060 |
Why?
|
| Malaria Vaccines | 1 | 2024 | 18 | 0.060 |
Why?
|
| Genome, Human | 1 | 2011 | 1255 | 0.060 |
Why?
|
| Genomics | 1 | 2011 | 1467 | 0.050 |
Why?
|
| Mass Spectrometry | 1 | 2024 | 324 | 0.050 |
Why?
|
| Colitis, Ulcerative | 2 | 1995 | 211 | 0.050 |
Why?
|
| Risk Factors | 1 | 2016 | 9717 | 0.050 |
Why?
|
| Toxicodendron | 1 | 2021 | 1 | 0.050 |
Why?
|
| Bryonia | 1 | 2021 | 1 | 0.050 |
Why?
|
| Gelsemium | 1 | 2021 | 1 | 0.050 |
Why?
|
| Strychnos nux-vomica | 1 | 2021 | 1 | 0.050 |
Why?
|
| Pulsatilla | 1 | 2021 | 1 | 0.050 |
Why?
|
| Homeopathy | 1 | 2021 | 4 | 0.050 |
Why?
|
| Arsenicals | 1 | 2021 | 15 | 0.050 |
Why?
|
| Proteomics | 1 | 2024 | 476 | 0.050 |
Why?
|
| Plant Extracts | 1 | 2021 | 116 | 0.040 |
Why?
|
| Porphyria, Acute Intermittent | 1 | 1996 | 3 | 0.030 |
Why?
|
| Chloroquine | 1 | 1996 | 32 | 0.030 |
Why?
|
| Telangiectasia, Hereditary Hemorrhagic | 1 | 1996 | 7 | 0.030 |
Why?
|
| Consensus Sequence | 2 | 2006 | 58 | 0.030 |
Why?
|
| Biliary Fistula | 1 | 1995 | 4 | 0.030 |
Why?
|
| Splints | 1 | 1995 | 10 | 0.030 |
Why?
|
| Chick Embryo | 1 | 2015 | 131 | 0.030 |
Why?
|
| Chest Tubes | 1 | 1995 | 36 | 0.030 |
Why?
|
| Pleural Diseases | 1 | 1995 | 27 | 0.030 |
Why?
|
| Chickens | 1 | 2015 | 637 | 0.030 |
Why?
|
| Fistula | 1 | 1995 | 50 | 0.030 |
Why?
|
| 3' Untranslated Regions | 1 | 2015 | 166 | 0.030 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 1995 | 80 | 0.030 |
Why?
|
| Gene Library | 1 | 2015 | 220 | 0.030 |
Why?
|
| Mice | 1 | 2011 | 17632 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 513 | 0.030 |
Why?
|
| Developing Countries | 1 | 1995 | 270 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2015 | 374 | 0.030 |
Why?
|
| Genome | 1 | 2015 | 471 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 2809 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2021 | 4623 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2015 | 1155 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2006 | 3886 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 864 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 1675 | 0.020 |
Why?
|
| Tuberculosis | 1 | 1994 | 570 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2021 | 15794 | 0.020 |
Why?
|
| DNA, Protozoan | 1 | 2006 | 29 | 0.020 |
Why?
|
| Endodeoxyribonucleases | 1 | 2006 | 47 | 0.020 |
Why?
|
| Adult | 4 | 2021 | 28548 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2006 | 284 | 0.020 |
Why?
|
| Middle Aged | 3 | 2021 | 25515 | 0.020 |
Why?
|
| Aged | 2 | 2021 | 18732 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 2005 | 212 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2006 | 793 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2005 | 293 | 0.010 |
Why?
|
| Male | 6 | 2021 | 59250 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2005 | 623 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2015 | 4518 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2005 | 2700 | 0.010 |
Why?
|
| Female | 4 | 2021 | 64574 | 0.010 |
Why?
|
| Prevalence | 2 | 1996 | 2322 | 0.010 |
Why?
|
| Ampicillin | 1 | 1995 | 58 | 0.010 |
Why?
|
| Colectomy | 1 | 1995 | 75 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 1995 | 215 | 0.010 |
Why?
|
| Endoscopy, Digestive System | 1 | 1996 | 154 | 0.010 |
Why?
|
| Metronidazole | 1 | 1995 | 155 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 1996 | 728 | 0.010 |
Why?
|
| Treatment Failure | 1 | 1995 | 335 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 1995 | 537 | 0.010 |
Why?
|
| Drainage | 1 | 1995 | 253 | 0.010 |
Why?
|
| Steroids | 1 | 1994 | 203 | 0.010 |
Why?
|
| Immunocompromised Host | 1 | 1994 | 300 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1996 | 1685 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 1995 | 1149 | 0.010 |
Why?
|
| Recurrence | 1 | 1995 | 1408 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 1996 | 1868 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 1995 | 12003 | 0.010 |
Why?
|
| Genetic Testing | 1 | 1996 | 988 | 0.010 |
Why?
|
| Child | 1 | 1996 | 23789 | 0.000 |
Why?
|